Overton’s Confirmation on Shaky Ground as Cassidy Still Has Questions
Senate HELP Committee chairman Bill Cassidy (R-LA says he remains undecided about FDA commissioner nominee Heidi Overton's confirmation prospects ahead of an 11/18 committee vote, raising the possibility that the agency could remain without a Senate-confirmed leader.
In a Sunday (11/15) interview on CBS's Face the Nation, Cassidy said he has spent the past week consulting with Overton, fellow Republicans and advisers but still has unresolved questions about her nomination.
“I don't know that,” Cassidy said when asked whether Overton would win committee approval. “I've been working the phones all week. Both speaking with Dr. Overton, speaking with others, I still have questions.” Cassidy said he had spoken with four or five Republican committee colleagues but could not predict the vote's outcome.
The senator previously expressed serious reservations about Overton's involvement in the Trump administration's childhood vaccination policies. Other Republican senators have raised concerns involving FDA's authorization of flavored vaping products, political interference in scientific reviews and the agency's regulation of mifepristone.
Cassidy acknowledged that rejecting Overton could leave FDA under a succession of temporary leaders potentially more susceptible to influence from HHS Secretary Robert F. Kennedy Jr.
“Do we want a series of short-term administrators who probably will have more influence from the secretary,” Cassidy asked, “as opposed to someone who may be not, you know, the perfect candidate in somebody's mind but at least would be a permanent one and have the ability to establish some independence?” He said he has heard competing arguments from people knowledgeable about FDA, including those who believe the agency needs stable leadership.
The uncertainty comes as Republicans attempt to advance administration nominees before Democrats assume control of the Senate in January.
In the same interview, Cassidy sharply criticized Kennedy's performance as HHS secretary, accusing him of failing to address rising healthcare costs and the resurgence of measles.
“If I were president, I would choose someone else,” Cassidy said, arguing that Kennedy should be held accountable for the administration's public health record.
Cassidy said the decision about Kennedy's future ultimately rests with President Trump.